Concepedia

Andrzej Mogielnicki

AM

Statistics

Publications

24

Citations

972

H-Index

19

Active since

2004

Affiliations

Medical University of Białystok(Current)

Jagiellonian University

University of Hyogo

Lodz University of Technology

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

Andrzej Mogielnicki is an author at Medical University of Białystok specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2004–2020

24

Publications

24

1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway

J Świȩs, Andrzej Mogielnicki, W Buczko et al. · British Journal of Pharmacology · 2007 · 198 citations · Full text

The physiological significance of the alternative pathways of angiotensin II production.

Karol Kramkowski, Andrzej Mogielnicki, W Buczko · PubMed · 2006 · 96 citations

, , +20

Antithrombotic Properties of Water-Soluble Carbon Monoxide-Releasing Molecules

Karol Kramkowski, Agnieszka Leszczyńska, Andrzej Mogielnicki et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 58 citations · Full text

Angiotensin II enhances thrombosis development in renovascular hypertensive rats

Andrzej Mogielnicki, Ewa Chabielska, Robert Pawlak et al. · Thrombosis and Haemostasis · 2005 · 56 citations

Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.

M. Kamińska, Andrzej Mogielnicki, Adrian Stankiewicz et al. · PubMed · 2005 · 54 citations

, , +21

Rows per page

1–5 of 24